Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Asia

Click here for a free trial

 

The Asia Pharma & Healthcare Insight service provides subscribers with analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Asia.  The service includes online access to the very latest analysis, a 24-month searchable archive of articles and data, and PDF access to the monthly Insight reports.

Please select which service(s) you would like to trial:





:

Disclaimer: The publisher reserves the right to determine whether the applicant qualifies for the requested trial. The applicant is eligible for one trial only to any BMI service. The trial cannot be repeated or extended.

To gain FREE trial access for a limited period, click trial.
To gain full access to content for 12 months, click subscribe.


Latest Stories

United States / Industry

Providing a small but welcome boost to the US generic drug market, Wal-Mart has expanded its low-priced prescription drug scheme. The world's largest retailer now offers a 90-day course of generic drug prescriptions for US$10, packs of brand-name over-the-counter (OTC) medicines for US$4, and has expanded its offerings of women's health products. As a result, consumers on low... 2008-05-08


India / Industry

It is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's... 2008-05-08


Pakistan / Industry

Due to erosion of margins, pharmaceutical companies have called on Pakistan's government to allow them to increase the price of medicines. The firms say that the price of drugs has... 2008-05-07


Company Spotlight

Japan

Overview

2007-02-12

Vietnam

Vinapharm is Vietnam's largest state-owned company, which owns all of the state-owned pharmaceutical-producing units.

2006-09-07

Hong Kong

Potential

2006-05-10

South Korea

Strengths

2006-02-23
Country Market Forecasts

BMI has marginally upgraded its projection for Japan's generic drug market after a basket of medicines lost patent protection and public knowledge of the benefit of this type of pharmaceutical... 2007-07-10


Pakistan

BMI has upwardly revised its projections for the Pakistan pharmaceutical market after new figures for 2007 were revealed at the Pak Pharma Expo. The market is currently valued at... 2007-04-26


Indonesia

BMI has slightly downgraded its forecast for the Indonesian pharmaceutical market after official figures showed contraction in the last quarter of 2006, primarily as a result of decreasing... 2007-03-19


Malaysia

As a focal point of regional-sector development, the Malaysian pharmaceutical market is expected to grow robustly in the short term. The pharmaceutical industry is currently valued... 2006-06-07

Industry Developments

United States

Providing a small but welcome boost to the US generic drug market, Wal-Mart has expanded its low-priced prescription drug scheme. The world's largest retailer now offers a 90-day... 2008-05-08


India

It is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's... 2008-05-08


Pakistan

Due to erosion of margins, pharmaceutical companies have called on Pakistan's government to allow them to increase the price of medicines. The firms say that the price of drugs has... 2008-05-07


India

To counter a 'lull' in US and Western Europe sales, GE Healthcare Life Sciences is targeting significantly increased demand in India for its tools that aid drug discovery. Over the... 2008-05-06